Transdermal Testosterone Attenuates Drug-Induced Lengthening of Both Early and Late Ventricular Repolarization in Older Men

dc.contributor.authorTomaselli Muensterman, Elena
dc.contributor.authorJaynes, Heather A.
dc.contributor.authorSowinski, Kevin M.
dc.contributor.authorOverholser, Brian R.
dc.contributor.authorShen, Changyu
dc.contributor.authorKovacs, Richard J.
dc.contributor.authorTisdale, James E.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-03-07T14:31:17Z
dc.date.available2024-03-07T14:31:17Z
dc.date.issued2021
dc.description.abstractWe have previously reported that transdermal testosterone attenuates drug-induced QT interval lengthening in older men. However, it is unknown whether this is due to modulation of early ventricular repolarization, late repolarization, or both. In a secondary analysis of a prospective, randomized, double-blind, placebo-controlled three-way crossover study, we determined if transdermal testosterone and oral progesterone attenuate drug-induced lengthening of early and late ventricular repolarization, represented by the electrocardiographic measurements J-Tpeak c and Tpeak -Tend , respectively, as well as Tpeak -Tend /QT, a measure of transmural dispersion of repolarization. Male volunteers ≥ 65 years of age (n = 14) were randomized to receive transdermal testosterone 100 mg, oral progesterone 400 mg, or matching transdermal/oral placebo daily for 7 days. On the morning following the seventh day, subjects received intravenous ibutilide 0.003 mg/kg, after which electrocardiograms were performed serially. One subject was excluded due to difficulty in T-wave interpretation. Pre-ibutilide J-Tpeak c was lower during the testosterone phase than during progesterone and placebo (216 ± 23 vs. 227 ± 28 vs. 227 ± 21 ms, P = 0.002). Maximum post-ibutilide J-Tpeak c was also lower during the testosterone phase (233 ± 22 vs. 246 ± 29 vs. 248 ± 23 ms, P < 0.0001). Pre-ibutilide Tpeak -Tend was not significantly different during the three phases, but maximum post-ibutilide Tpeak -Tend was lower during the testosterone phase (80 ± 12 vs. 89 ± 18 vs. 86 ± 15 ms, P = 0.002). Maximum Tpeak -Tend /QT was also lower during the testosterone phase (0.199 ± 0.023 vs. 0.216 ± 0.035 vs. 0.209 ± 0.031, P = 0.005). Progesterone exerted minimal effect on drug-induced lengthening of J-Tpeak c, and no effect on Tpeak -Tend or Tpeak -Tend /QT. Transdermal testosterone attenuates drug-induced lengthening of both early and late ventricular repolarization in older men.
dc.eprint.versionAuthor's manuscript
dc.identifier.citationTomaselli Muensterman E, Jaynes HA, Sowinski KM, et al. Transdermal Testosterone Attenuates Drug-Induced Lengthening of Both Early and Late Ventricular Repolarization in Older Men. Clin Pharmacol Ther. 2021;109(6):1499-1504. doi:10.1002/cpt.2072
dc.identifier.urihttps://hdl.handle.net/1805/39083
dc.language.isoen_US
dc.publisherWiley
dc.relation.isversionof10.1002/cpt.2072
dc.relation.journalClinical Pharmacology & Therapeutics
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectAnti-arrhythmia agents
dc.subjectElectrocardiography
dc.subjectProgesterone
dc.subjectSulfonamides
dc.subjectTestosterone
dc.titleTransdermal Testosterone Attenuates Drug-Induced Lengthening of Both Early and Late Ventricular Repolarization in Older Men
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-1889638.pdf
Size:
497.59 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: